EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Occurrence of Cold Agglutinin Disease among Patients with Autoimmune Hemolytic Anemia: A Hungarian Single-Center Experience

Boglárka Brugós, Márta Kerecsenyi, Zsófia Simon, Árpád Illés

Transfusion Medicine and Hemotherapy · 16.04.2026 · 1-10

DOI: 10.1159/000551422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion Medicine and Hemotherapy, online erschienen am 16.04.2026. Verfasst von Boglárka Brugós und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Institute for Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cold agglutinin disease is a rare autoimmune hemolytic anemia, a low-grade lymphoproliferative disease. Our objective was to determine the occurrence of cold agglutinin disease among patients with autoimmune hemolytic anemia and to map its specific characteristics, with a particular focus on thromboembolic complications.

Methods

In a Hungarian hematology center, we retrospectively studied clinical data, laboratory parameters, and therapy of 84 patients with autoimmune hemolytic anemia.

Results

A total of 17% of patients had cold autoimmune hemolytic anemia, with 8 patients fulfilling the criteria for cold agglutinin disease and 7 patients having cold agglutinin syndrome. Most patients were older than 70 years, and the disease was more common in women (49 women, 35 men). Here, 71% of patients with CAD were administered rituximab, while some received additional chemotherapy. The 10-year survival rate was significantly worse in cold-type hemolytic anemia than in warm-type autoimmune hemolytic anemia (66.7% vs. 82.4%). Congenital and acquired causes of thrombophilia were examined in patients with severe hemolysis (hemoglobin 1.5× the upper limit of normal) and in cases with thromboembolic complications.

Conclusion

This is the first case series from a country in Central Eastern Europe with a four-season climate, demonstrating the occurrence of cold autoimmune hemolytic anemia. Overall survival was influenced by age, type of hemolytic anemia, and total bilirubin level during presentation. Inherited and acquired thrombophilia risk factors and antiphospholipid antibodies were detected in more patients with cold autoimmune hemolytic anemia than those with warm autoimmune hemolytic anemia.

Schlagwörter

Stichwörter der Autor:innen

Antiphospholipid antibodiesAutoimmune hemolytic anemiaCold agglutinin diseaseRituximab

Autor:innen und Institutionen

  • Department of Hematology, Institute for Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Doctoral School of Clinical Sciences, University of Debrecen, Debrecen, Hungary.
  • Department of Pediatric Oncohematology and Bone Marrow Transplantation, Borsod-Abaúj-Zemplén County Central Hospital and University Teaching Hospital, Miskolc, Hungary.

Zitieren

APA

Brugós, B., Kerecsenyi, M., Simon, Z., & Illés, Á. (2026). Occurrence of Cold Agglutinin Disease among Patients with Autoimmune Hemolytic Anemia: A Hungarian Single-Center Experience. Transfusion Medicine and Hemotherapy, 1-10. https://doi.org/10.1159/000551422

Vancouver

Brugós B, Kerecsenyi M, Simon Z, Illés Á. Occurrence of Cold Agglutinin Disease among Patients with Autoimmune Hemolytic Anemia: A Hungarian Single-Center Experience. Transfusion Medicine and Hemotherapy. 2026:1-10. doi:10.1159/000551422

BibTeX
@article{Brugs2026,
  author = {Brugós, Boglárka and Kerecsenyi, Márta and Simon, Zsófia and Illés, Árpád},
  title = {Occurrence of Cold Agglutinin Disease among Patients with Autoimmune Hemolytic Anemia: A Hungarian Single-Center Experience},
  journal = {Transfusion Medicine and Hemotherapy},
  year = {2026},
  pages = {1--10},
  doi = {10.1159/000551422}
}
Kostenlos starten →